Oklahoma SB2024 mandates pharmaceutical manufacturers to publish ingredient lists and face penalties for noncompliance.
Oklahoma SB2024 requires pharmaceutical product manufacturers to disclose complete ingredient lists, including active and inactive components, biological materials, and their origins. These lists must be submitted to the State Board of Pharmacy, published on manufacturer websites, and included in product labeling and marketing materials. Noncompliance results in escalating fines, prohibition of operations, and criminal liability. Whistleblowers are protected from retaliation and may receive a portion of collected fines.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.